Resources

CFD has received permission and is starting a phase III study of a Russian drug for the treatment of patients with COVID-19.

This drug is intended for the treatment of a wide range of viral infections and is a purine nucleoside that acts as a competitive inhibitor of viral RNA-dependent RNA…

The CF team is pleased to announce the randomization of 220 patients with COVID-19 in a Phase III clinical trial in record time.

Less than three weeks passed from the opening of the first clinical center to the randomization of the last subject.

This success was achieved thanks to …

Klinfarm Development LLC is starting to develop a package of documents for conducting new clinical trials.

Klinfarm Development (CFD) has successfully launched two Phase III multicenter studies to study the safety and efficacy of two drugs aimed at combating the new COVID-19 infection.

Both drugs are representatives of antiviral agents that exhibit antiviral activity against a number of single-stranded…

ClinPharmDevelopment, despite the difficult situation associated with coronavirus infection, has successfully launched studies of comparative pharmacokinetics and bioequivalence of drugs that are used in various nosologies: immunology, hematology, infectious diseases.

Studies are conducted …

The team of Klinfarm Development LLC completed the recruitment of 333 patients in a multicenter pediatric phase III study involving children 6−12 years old with an established diagnosis of attention deficit hyperactivity disorder (ADHD).

We are very pleased that during the complicated epidemiological…

ClinPharmDevelopment begins developing a package of documents for conducting a clinical study of the safety and effectiveness of a foreign medicinal product for the treatment of allergic dermatoses.

The main priority of the CFD is the safety and preservation of human health.

In the face of a pandemic, our team is taking the necessary steps to protect the health, well-being and well—being of our employees, their families, colleagues, research subjects, while at the same time ensuring that…

ClinPharmDevelopment has started developing a Master file of the pharmacovigilance system for a foreign drug used for the treatment of venous lymphatic insufficiency and symptoms associated with acute hemorrhoid attacks.